HY-P99794-1mg
|
MedChemexpress LLC
|
Osocimab [CAS 2056878-75-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99794-10mg
|
MedChemexpress LLC
|
Osocimab [CAS 2056878-75-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99794-5mg
|
MedChemexpress LLC
|
Osocimab [CAS 2056878-75-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-130521-100mg
|
MedChemexpress LLC
|
Pomalidomide-amido-PEG3-C2-NH2 [CAS 2328070-52-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9951A-1mg
|
MedChemexpress LLC
|
Ranibizumab (anti-VEGF) [CAS 347396-82-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9951A-10mg
|
MedChemexpress LLC
|
Ranibizumab (anti-VEGF) [CAS 347396-82-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9951A-5mg
|
MedChemexpress LLC
|
Ranibizumab (anti-VEGF) [CAS 347396-82-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9951-1mg
|
MedChemexpress LLC
|
Ranibizumab [CAS 347396-82-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99891-1mg
|
MedChemexpress LLC
|
Rovelizumab [CAS 339086-79-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99891-10mg
|
MedChemexpress LLC
|
Rovelizumab [CAS 339086-79-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99891-5mg
|
MedChemexpress LLC
|
Rovelizumab [CAS 339086-79-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9934-1mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9934-10mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9934-5mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9928A-2mg
|
MedChemexpress LLC
|
Alirocumab (anti-PCSK9) [CAS 1245916-14-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9928A-5mg
|
MedChemexpress LLC
|
Alirocumab (anti-PCSK9) [CAS 1245916-14-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99105-1mg
|
MedChemexpress LLC
|
Anselamimab [CAS 2414866-63-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99105-10mg
|
MedChemexpress LLC
|
Anselamimab [CAS 2414866-63-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99105-5mg
|
MedChemexpress LLC
|
Anselamimab [CAS 2414866-63-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99441-1mg
|
MedChemexpress LLC
|
Apitegromab [CAS 2278276-46-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99441-10mg
|
MedChemexpress LLC
|
Apitegromab [CAS 2278276-46-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99441-5mg
|
MedChemexpress LLC
|
Apitegromab [CAS 2278276-46-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1449A-10mg
|
MedChemexpress LLC
|
Boc-Gly-Gly-Phe-Gly-OH (TFA) [CAS 2450273-39-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1449A-5mg
|
MedChemexpress LLC
|
Boc-Gly-Gly-Phe-Gly-OH (TFA) [CAS 2450273-39-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9987-1mg
|
MedChemexpress LLC
|
Crizanlizumab [CAS 1690318-25-2]
|
|
Neuroscience-Neuromodulation
|
|